Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Berger, Thomas G ^a,c   Schulze Koops, Hendrik ^a,d   Schäfer, Michaela ^a   Müller, Ester ^a   Lutz, Manfred B ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MATURATION; CLONAL ANERGY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; PROTEIN EXPRESSION; UPREGULATION; CYTOLOGY; IMMUNOLOGY; T LYMPHOCYTE;

BONE MARROW CELLS; CLONAL ANERGY; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; T-LYMPHOCYTES;

EID: 69949103844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006645     Document Type: Article

References (50)

1. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Steinman RM, Nussenzweig MC (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99: 351-358.
3. Bluestone JA, Thomson AW, Shevach EM, Weiner HL (2007) What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol 7: 650-654.
4. Fathman CG, Lineberry NB (2007) Molecular mechanisms of CD4+ T-cell anergy. Nat Rev Immunol 7: 599-609.
5. Parish IA, Rao S, Smyth GK, Juelich T, Denyer GS, et al. (2009) The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood 113: 4575-4585.
6. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
7. Lutz MB (2006) Differentiation stages and subsets of tolerogenic dendritic cells. In: Lutz MB, Romani N, Steinkasserer A, eds (2006) Handbook of Dendritic Cells Biology, Diseases and Therapy. Weinheim: VCH-Wiley. pp 517-543.
8. Schwartz RH, Mueller DL, Jenkins MK (1989) T-cell clonal anergy. Cold Spring Harbor Symp Quant Biol 54: 605-610.
9. Melamed D, Friedman A (1993) Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 23: 935-942.
10. Kawabe Y, Ochi A (1990) Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J Exp Med 172: 1065-1070.
11. Macian F, Im SH, Garcia-Cozar FJ, Rao A (2004) T-cell anergy. Curr Opin Immunol 16: 209-216.
12. Lutz MB, Kukutsch N, Ogilvie AL, Rößner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
13. Gallucci S, Lolkema M, Matzinger P (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5: 1249-1255.
14. Reis e Sousa C (2001) Dendritic cells as sensors of infection. Immunity 14: 495-498.
15. Howland KC, Ausubel LJ, London CA, Abbas AK (2000) The roles of CD28 and CD40 ligand in T cell activation and tolerance. J Immunol 164: 4465-4470.
16. Thomson AW, Sacks JM, Kuo YR, Ikeguchi R, Horibe EK, et al. (2009) Dendritic cell therapy in composite tissue allotransplantation. Transplant Proc 41: 537-538.
17. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD (1991) Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4 T helper cells. J Immunol 146: 485-491.
18. Sato K, Yamashita N, Baba M, Matsuyama T (2003) Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18: 367-379.
19. Turnquist HR, Thomson AW (2008) Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation. Curr Opin Organ Transplant 13: 350-357.
20. Adorini L, Penna G (2009) Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 70: 345-352.
21. Zahorchak AF, Kean LS, Tokita D, Turnquist HR, Abe M, et al. (2007) Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation 84: 196-206.
22. Fu F, Li Y, Qian S, Lu L, Chambers F, et al. (1996) Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62: 659-665.
23. Lutz MB, Suri RM, Niimi M, Ogilvie ALJ, Kukutsch NA, et al. (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation-resistant and prolong allograft survival in vivo. Eur J Immunol 30: 1813-1822.
24. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27.
25. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 28-50.
26. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, et al. (2007) Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27: 610-624.
27. Sato K, Yamashita N, Baba M, Matsuyama T (2003) Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 101: 3581-3589.
28. Woltman AM, de Fijter JW, Kamerling SW, Paul LC, Daha MR, et al. (2000) The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30: 1807-1812.
29. van Kooten C, Stax AS, Woltman AM, Gelderman KA (2009) Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DC. Handb Exp Pharmacol. pp 233-249.
30. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, et al. (1998) Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101: 252-262.
31. Stax AM, Gelderman KA, Schlagwein N, Essers MC, Kamerling SW, et al. (2008) Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models. Transplantation 86: 1275-1282.
32. Vlad G, Chang CC, Colovai AI, Berloco P, Cortesini R, et al. (2009) Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function. Hum Immunol 70: 340-344.
33. Menges M, Baumeister T, Rößner S, Stoitzner P, Romani N, et al. (2005) IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J Leukoc Biol 77: 535-543.
34. Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont RJ, et al. (2000) Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 192: 823-833.
35. Lutz MB, Schnarre M, Rößner S, Röllinghoff M, Schuler G, et al. (2002) Differential functions of IL-4R type I and II for dendritic cell maturation and IL-12 production. 169: 3574-3580.
36. Dietze B, Cierpka E, Schäfer M, Schill W, Lutz MB (2008) An improved method to generate equine dendritic cells from peripheral blood mononuclear cells: Divergent maturation programs by IL-4 and LPS. Immunobiol 213: 751-758.
37. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192: 1213-1222.
38. Berthier-Vergnes O, Bermond F, Flacher V, Massacrier C, Schmitt D, et al. (2005) TNF-alpha enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production. FEBS Lett 579: 3660-3668.
39. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, et al. (2001) Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood 97: 3470-3477.
40. Velasquez-Lopera MM, Correa LA, Garcia LF (2008) Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes. Clin Exp Immunol 154: 107-114.
41. Yamazaki S, Dudziak D, Heidkamp GF, Fiorese C, Bonito AJ, et al. (2008) CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol 181: 6923-6933.
42. Powell JD, Lerner CG, Schwartz RH (1999) Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol 162: 2775-2784.
43. DeSilva DR, Urdahl KB, Jenkins MK (1991) Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol 147: 3261-3267.
44. Verdoodt B, Blazek T, Rauch P, Schuler G, Steinkasserer A, et al. (2003) The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy. Eur J Immunol 33: 3154-3163.
45. Wells AD, Walsh MC, Bluestone JA, Turka LA (2001) Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 108: 895-903.
46. Schneider H, Valk E, Leung R, Rudd CE (2008) CTLA-4 activation of phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death. PLoS ONE 3: e3842.
47. Krummel MF, Allison JP (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182: 459-465.
48. Valk E, Rudd CE, Schneider H (2008) CTLA-4 trafficking and surface expression. Trends Immunol 29: 272-279.
49. Peggs KS, Quezada SA, Allison JP (2008) Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol Rev 224: 141-165.
50. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, et al. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196: 137-151.